To The Moon

* All eyes on Fed's policy meeting later this week * Indexes: Dow down 1.8%, S&P 500 down 1.7%, Nasd

The CEO of ARK Invest is averaging down on these compelling life-science stocks.

NEW YORK - US stocks ended sharply lower in a broad sell-off on Friday , ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.All three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.They also posted weekly losses, with the S&P index suffering its biggest tw

Summary Since our first valuation of the stock, the price has gone up more than 20%. At that time,

Sometimes the best thing you can do for your portfolio is just leave some of its holdings alone... for years at a time.

NEW YORK (Reuters) - Wall Street lost ground on Tuesday as economic uncertainties and the increasing

Traders this week will be focused on new data on inflation and spending. Each are likely to have mod

* Indexes end: S&P 500 -0.34%, Nasdaq +0.07%, Dow -0.76%. The S&P 500 closed lower on Tuesday while the Nasdaq edged up to a record high, as investors balanced worries about the slowing pace of economic recovery with expectations that the Federal Reserve will maintain its accommodative monetary policy.Amgen Inc fell 2.2% and Merck & Co lost 1.7% after $Morgan Stanley$ cut its rating on the stocks to "equal-weight" from "overweight.". The Nasdaq was supported by Big Tech stocks that have fueled W